Reuter VE - Search Results

1

Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications.

Akbulut D, Whiting K, Teo MY, Tallman JE, Ozcan GG, Basar M, Jia L, Rammal R, Chen JF, Sarungbam J, Chen YB, Gopalan A, Fine SW, Tickoo SK, Mehra R, Baine M, Bochner BH, Pietzak EJ, Bajorin DF, Rosenberg JE, Iyer G, Solit DB, Reuter VE, Rekhtman N, Ostrovnaya I, Al-Ahmadie H. Akbulut D, et al. Among authors: reuter ve. Mod Pathol. 2024 Oct;37(10):100557. doi: 10.1016/j.modpat.2024.100557. Epub 2024 Jul 2. Mod Pathol. 2024. PMID: 38964503

2

Phase II trial of suramin in patients with advanced renal cell carcinoma: treatment results, pharmacokinetics, and tumor growth factor expression.

Motzer RJ, Nanus DM, O'Moore P, Scher HI, Bajorin DF, Reuter V, Tong WP, Iversen J, Louison C, Albino AP, et al. Motzer RJ, et al. Cancer Res. 1992 Oct 15;52(20):5775-9. Cancer Res. 1992. PMID: 1394202 Clinical Trial.

3

Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologies.

Motzer RJ, Rodriguez E, Reuter VE, Samaniego F, Dmitrovsky E, Bajorin DF, Pfister DG, Parsa NZ, Chaganti RS, Bosl GJ. Motzer RJ, et al. Among authors: reuter ve. J Natl Cancer Inst. 1991 Mar 6;83(5):341-6. doi: 10.1093/jnci/83.5.341. J Natl Cancer Inst. 1991. PMID: 1847433

4

Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC.

Sarkis AS, Bajorin DF, Reuter VE, Herr HW, Netto G, Zhang ZF, Schultz PK, Cordon-Cardo C, Scher HI. Sarkis AS, et al. Among authors: reuter ve. J Clin Oncol. 1995 Jun;13(6):1384-90. doi: 10.1200/JCO.1995.13.6.1384. J Clin Oncol. 1995. PMID: 7751883

5

Bladder cancer: advances in biology and treatment.

Bosl GJ, Fair WR, Herr HW, Bajorin DF, Dalbagni G, Sarkis AS, Reuter VE, Cordon-Cardo C, Sheinfeld J, Scher HI. Bosl GJ, et al. Among authors: reuter ve. Crit Rev Oncol Hematol. 1994 Feb;16(1):33-70. doi: 10.1016/1040-8428(94)90041-8. Crit Rev Oncol Hematol. 1994. PMID: 8074800 Review.

6

Can p53 help select patients with invasive bladder cancer for bladder preservation?

Herr HW, Bajorin DF, Scher HI, Cordon-Cardo C, Reuter VE. Herr HW, et al. Among authors: reuter ve. J Urol. 1999 Jan;161(1):20-2; discussion 22-3. J Urol. 1999. PMID: 10037358

7

Renal oncocytosis: a morphologic study of fourteen cases.

Tickoo SK, Reuter VE, Amin MB, Srigley JR, Epstein JI, Min KW, Rubin MA, Ro JY. Tickoo SK, et al. Among authors: reuter ve. Am J Surg Pathol. 1999 Sep;23(9):1094-101. doi: 10.1097/00000478-199909000-00013. Am J Surg Pathol. 1999. PMID: 10478670

8

Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma.

Genega EM, Hutchinson B, Reuter VE, Gaudin PB. Genega EM, et al. Among authors: reuter ve. Mod Pathol. 2000 Nov;13(11):1186-91. doi: 10.1038/modpathol.3880220. Mod Pathol. 2000. PMID: 11106075

9

Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse.

Rabbani F, Sheinfeld J, Farivar-Mohseni H, Leon A, Rentzepis MJ, Reuter VE, Herr HW, McCaffrey JA, Motzer RJ, Bajorin DF, Bosl GJ. Rabbani F, et al. Among authors: reuter ve. J Clin Oncol. 2001 Apr 1;19(7):2020-5. doi: 10.1200/JCO.2001.19.7.2020. J Clin Oncol. 2001. PMID: 11283135

10

Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens.

Bochner BH, Herr HW, Reuter VE. Bochner BH, et al. Among authors: reuter ve. J Urol. 2001 Dec;166(6):2295-6. J Urol. 2001. PMID: 11696756

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

567 results

Search Page

Filters